Kenvue

By Fortune EditorsNovember 7, 2025

Investing‘This team is guided by science’: Kenvue chief hits back at Trump and RFK Jr.’s Tylenol autism claims in memo to 20,000 employees
By Ashley LutzOctober 1, 2025

HealthTylenol-maker Kenvue’s stock has lost a quarter of its value in 6 months as momentum grows for autism link despite repeated denials
By Sasha RogelbergSeptember 22, 2025

InvestingTylenol maker’s stock lost billions after a rumor linking the medicine to autism. Wall Street says buy the dip as one bank sees a ‘major overreaction’
By Nick LichtenbergSeptember 9, 2025

By Ashley LutzSeptember 8, 2025

By Fortune EditorsSeptember 5, 2025

By Fortune EditorsAugust 8, 2025
Most Popular



